v3.26.1
Condensed Consolidated Statements of Cash Flows - USD ($)
3 Months Ended 6 Months Ended 12 Months Ended
Jun. 30, 2026
Mar. 31, 2026
Jun. 30, 2025
Mar. 31, 2025
Jun. 30, 2026
Jun. 30, 2025
Dec. 31, 2025
Cash flows from operating activities:              
Net income $ 653,021 $ 1,299,135 $ 93,363 $ 967,796 $ 1,952,156 $ 1,061,159  
Adjustments to reconcile net income to net cash provided by operating activities:              
Depreciation and amortization         829,001 807,730  
Net loss on disposition or impairment         1,427,651 2,892,265  
Net franchise fees recognized upon termination of franchise agreements         (395,159) (174,285)  
Provision for credit losses         122,823 0 $ 286,232
Stock-based compensation expense         703,180 624,929  
Changes in operating assets and liabilities, net of acquisitions:              
Accounts receivable         454,019 1,558,183  
Prepaid expenses and other current assets         (833,199) (1,743,981)  
Deferred franchise costs         408,499 183,839  
Deposits and other assets         34,849 18,332  
Accounts payable         (607,825) (91,075)  
Accrued expenses         629,565 (3,408,504)  
Payroll liabilities         (2,560,203) (1,446,598)  
Operating leases         (1,615,535) (2,719,624)  
Deferred revenue         (625,793) (508,565)  
Upfront regional developer fees         (238,727) (145,605)  
Other liabilities         1,030,748 259,795  
Net cash provided by (used in) operating activities         716,050 (2,832,005)  
Cash flows from investing activities:              
Proceeds from sale of clinics         1,160,284 7,778,287  
Purchase of property and equipment         (490,858) (836,545)  
Net cash provided by investing activities         669,426 6,941,742  
Cash flows from financing activities:              
Payments of finance lease obligation         0 (4,354)  
Purchases of treasury stock under employee stock plans         (74,983) (8,440)  
Purchases of treasury stock under employee stock plans         (1,821,864) 0  
Proceeds from exercise of stock options         37,228 905,976  
Net cash (used in) provided by financing activities         (1,859,619) 893,182  
(Decrease) increase in cash, cash equivalents and restricted cash         (474,143) 5,002,919  
Cash, cash equivalents and restricted cash, beginning of period   $ 24,301,868   $ 25,996,436 24,301,868 25,996,436 25,996,436
Cash, cash equivalents and restricted cash, end of period 23,827,725   30,999,355   23,827,725 30,999,355 24,301,868
Reconciliation of cash, cash equivalents and restricted cash:              
Cash and cash equivalents 22,157,203   29,811,667   22,157,203 29,811,667 23,601,810
Restricted cash 1,670,522   1,187,688   1,670,522 1,187,688  
Cash, cash equivalents and restricted cash, end of period $ 23,827,725   $ 30,999,355   23,827,725 30,999,355 $ 24,301,868
Net cash paid for:              
Interest         25,139 25,139  
Income taxes, net of refunds         145,079 382,419  
Non-cash investing and financing activity:              
Unpaid purchases of property and equipment         $ 60,500 $ 7,488